A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis. Kennedy GA, Tey SK, Buizen L, Varelias A, et al. Blood 2021;137:1970-1979.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kennedy GA, Tey SK, Buizen L, Varelias A, et al. A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis. Blood 2021;137:1970-1979.
PMID: 33512442